论文部分内容阅读
甲磺酸伊马替尼(商品名:格列卫)是慢性粒细胞白血病(chronic myelogenous leukemia,CML)的分子靶向性药物,对慢性粒细胞白血病慢性期患者剂量为400 mg/d,对急变期和加速期患者剂量为600 mg/d。我院收治的1例CML慢性期患者过量误服甲磺酸伊马替尼1200 mg/d,连续10 d,并无明显的药物
Imatinib mesylate (product name: Gleevec) is a molecular targeted drug for chronic myelogenous leukemia (CML), chronic patients with chronic myeloid leukemia in patients with a dose of 400 mg / d, Patient’s dosage for acute phase and accelerated phase is 600 mg / d. One patient with chronic CML admitted to our hospital overdosed with imatinib mesylate 1200 mg / d for 10 consecutive days without obvious medication